About Luminous Ventures
Luminous Ventures is a venture capital firm founded in 2018. It is primarily based out of London, United Kingdom. As of Mar 2026, Luminous Ventures is an active investor, having invested in 28 companies, with 1 new investment in the last 12 months. It primarily invests in Seed round in United Kingdom based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to High Tech and Life Sciences. Most recently it participated in the $***** Series D round of Earendil Overall, Luminous Ventures portfolio has seen 1 acquisition, namely BioBeats. A lot of funds co-invest with Luminous Ventures, with names like SJF Ventures sharing a substantial percentage of its portfolio. Luminous Ventures has team of 5 people including 3 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed, Series A & 2 more
Portfolio Acquisitions
Deals in last 12 months
Luminous Ventures' List of Top Investments
Luminous Ventures has a portfolio of 28 companies. Their most notable investments are in Treos Bio and Optellum.Their portfolio spans across United Kingdom, United States, Canada and 3 more locations. They have invested in Enterprise Applications, High Tech, Life Sciences and 13 other sectors, across stages such as Seed, Series A and 2 more. Here is the list of top investments by Luminous Ventures:
1. Huma
Developer of regulated software platforms for digital health care workflows. These systems unify clinical, operational, and research data to facilitate patient monitoring, triage, and clinical documentation. The technology provides tools for building applications that support remote patient management, emergency department assessments, and population health screening. By integrating disparate digital health systems, the infrastructure enables the automation of clinical tasks and the structured collection of medical information. The platform supports the deployment of tools for managing chronic conditions and conducting research studies through digital interfaces.
Key facts about Huma
- Founded Year: 2011
- Location: London (United Kingdom)
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $355M
- Employee Count: 285 as on Jul 31, 2026
- Investors: Nomura, HV Capital and 100 Others
- Latest Funding Round: Series D, Apr 25, 2025, $*****
- Highlight: Editors' Pick
2. Optellum
Provider of AI-based cancer diagnostics platform. The company has developed an AI-based platform to detect cancer with the help of big data and image analysis. Its platform identifies different symptoms with the help of machine learning and medical imaging data. The company claims that its platform helps the clinician to identify cancer in initial stage which helps the patient to get proper treatment as per diagnostics results.
Key facts about Optellum
- Founded Year: 2015
- Location: Oxford (United Kingdom)
- Valuation: $*****
- Stage: Series A
- Total Funding till date: $20.6M
- Employee Count: 50 as on Jul 31, 2026
- Investors: IQ Capital, EIC Fund and 35 Others
- Latest Funding Round: Series A, Sep 27, 2022, $*****
- Highlight: Editors' Pick
Provider of an AI-based app for behavioral health monitoring. The platform uses AI to capture a conversation between the patient and the doctor during a clinic visit. The platform uses deep learning algorithms to process the speech and to monitor and provide real-time behavioral health assessments that are shared with the healthcare providers. The platform monitors patients suffering from depression, anxiety, and other behavioral health issues.
Key facts about Ellipsis Health
- Founded Year: 2017
- Location: San Francisco (United States)
- Stage: Series A
- Total Funding till date: $75M
- Employee Count: 92 as on Jul 31, 2026
- Investors: AME Cloud Ventures, Able Partners and 25 Others
- Latest Funding Round: Series A, Jun 12, 2025, $*****
- Highlight: Editors' Pick
Developer of mRNA therapeutics for immuno-oncology using deep learning technology. The company is developing platforms using deep learning algorithms and big data to design better mRNA therapeutics. The platform helps in three processes: codon-engineering, smart designing and non-immunogenic selection.
Key facts about Kernal Biologics
- Founded Year: 2016
- Location: Cambridge (United States)
- Stage: Series A
- Total Funding till date: $35.9M
- Employee Count: 21 as on Jul 31, 2026
- Investors: SymBiosis, Uncommon Denominator and 20 Others
- Latest Funding Round: Grant (prize money), Oct 07, 2025, $*****
- Highlight: Editors' Pick
5. Synthace
Developer of software for automating biological experiments and data analysis. This platform enables the design and execution of multivariate experiments to generate structured datasets. It integrates with laboratory hardware to manage experimental workflows and standardize data collection. The software assists in assay development, media optimization, and purification processes by facilitating the management of experimental variables.
Key facts about Synthace
- Founded Year: 2011
- Location: London (United Kingdom)
- Annual Revenue: £1M - £10M as on May 31, 2025
- Valuation: $*****
- Stage: Series C
- Total Funding till date: $80.3M
- Employee Count: 35 as on Jul 31, 2026
- Investors: 11.2 Capital, UCL Technology Fund and 56 Others
- Latest Funding Round: Series C, Nov 16, 2021, $*****
- Highlight: Editors' Pick
Luminous Ventures' Year-on-Year Investment Trends
Luminous Ventures has invested in 28 companies over the last 18 years, with an average of 2 new investments annually in the last 10 years. As of Mar 2026, it has made 1 investment in this year. Its most recent first time investment was in Earendil and most recent follow-on round was in LGN.Year | No. of Investments | ||
|---|---|---|---|
1st Round | Follow-on | Total | |
2026 (YTD) | 1 | 0 | 1 |
2025 | 0 | 0 | 0 |
2024 | 0 | 0 | 0 |
2023 | 0 | 0 | 0 |
2022 | 0 | 0 | 0 |
2021 | 4 | 1 | 5 |
2020 | 6 | 0 | 6 |
2019 | 4 | 0 | 4 |
2018 | 1 | 0 | 1 |
Luminous Ventures' Investments by Stage
Luminous Ventures has made 10 investments in Seed stage with an average round size of $2.92M, 4 investments in Series A stage with an average round size of $13.6M, 2 investments in Series B stage with an average round size of $19.8M and 1 investment in Series D stage with an average round size of $787M.Stage of entry | No. of Investments |
|---|---|
Seed | 10 |
Series A | 4 |
Series B | 2 |
Series D | 1 |
Note: We have considered here, only first round of investments
Luminous Ventures' Investments by Sector
Luminous Ventures has a diverse portfolio, with companies operating in the Enterprise Applications, HealthTech, High Tech, Life Sciences and Aerospace, Maritime and Defense Tech. Notably, it has invested in 22 Tech companies, 20 Enterprise (B2B) companies, 15 Software companies and at least 5 companies focusing on Consumer (B2C).Sector | No. of Investments |
|---|---|
Enterprise Applications | 8 |
HealthTech | 7 |
High Tech | 7 |
Life Sciences | 7 |
Aerospace, Maritime and Defense Tech | 2 |
Others | 14 |
Note: We have considered here, only first round of investments
Luminous Ventures' Investments by Geography
Luminous Ventures has made most investments in United Kingdom (10), followed by United States where it has made 4 investments.Country | No. of Investments |
|---|---|
United Kingdom | 10 |
United States | 4 |
Canada | 1 |
India | 1 |
Poland | 1 |
Note: We have considered here, only first round of investments
Luminous Ventures' recent investments
Luminous Ventures has made 1 investments in 2026 so far - Earendil.Here are the most recent investments by Luminous Ventures:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Mar 20, 2026 | United States | Series D | 3766 | [+5] | |
Aug 31, 2021 | United States | Series A | 6950 | [+15] | |
May 04, 2021 | Poland | Seed | 4154 | [+6] | |
Mar 31, 2021 | United Kingdom | Series B | 9251 | ||
Mar 23, 2021 | United Kingdom | Series A | 7377 |
Acquired companies in Luminous Ventures' Portfolio
1 company from Luminous Ventures' portfolio has been acquired. The most recent acquisition was BioBeats in Apr 2020 by Huma for $*****.Here are Luminous Ventures' portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Apr 16, 2020 | - | - | 8431 |
Team profile of Luminous Ventures
Luminous Ventures has a team of 5 members including 3 Partners and 1 Venture Partner located in United States and United Kingdom. Luminous Ventures' team does not sit on the board of any company as of now.Here is a list of all team members in Luminous Ventures:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | - | - | - | |
Partner | Corona | - | - | |
Partner | Erie | - | - | |
Venture Partner | Cambridge | - |
Co-investors of Luminous Ventures
Over the past 18 years, 155 investors have co-invested in Luminous Ventures's portfolio companies. This includes funds and angels.
- Invested before Luminous Ventures: White Cloud Capital, UK Innovation Science & Seed Fund and 19 others have invested in rounds before Luminous Ventures. There are 2 companies where White Cloud Capital has invested before Luminous Ventures and 2 companies where UK Innovation Science & Seed Fund has invested before Luminous Ventures.
- Top Co-investors of Luminous Ventures: 70 investors entered a company along with Luminous Ventures. These include investors like SJF Ventures (1 company).
- Invested after Luminous Ventures: A total of 64 investors have invested in Luminous Ventures's portfolio after their investments. Top Investors include Ukri (2 companies), 7percent Ventures (2 companies) and Alumni Ventures (2 companies).
Recent News related to Luminous Ventures
•
Inverse Matrix Technology Raises Over $100 Million in Seed++ RoundTMTpost•Jun 17, 2026•Luminous Ventures, Hillhouse, Ant Group, 5Y Capital and 1 other
•
Native AI IP firm Lightbringer raises $10m in Series A funding roundGlobal Legal Post•Jun 17, 2026•Luminous Ventures
•
Luminous Ventures Closes USD 700 Million+ Dual-Currency FundsPandaily•Apr 15, 2026•Luminous Ventures
•
Alibaba cloud backs AI video startup ShengShu in $293m roundTech in Asia•Apr 10, 2026•ShengShu Technology, Alibaba, Luminous Ventures, Baidu Venture Capital and 6 others
•
Sensorion Reports Full-Year 2025 Results, Provides Corporate Update and Announces Release of Annual ReportBusiness Wire•Mar 18, 2026•Sensorion, Sanofi, Dimension Capital Management, Pfizer and 7 others
•
US AI drug startup Earendil said to consider Hong Kong IPOTech in Asia•Mar 13, 2026•Earendil, Dimension, Luminous Ventures, DST Global
•
Ellipsis Health Raises $26M in Series A FundingFinSMEs•Aug 31, 2021•Ellipsis Health, SJF Ventures, Able Partners, Alumni Ventures and 9 others
•
Molecule.one grows its drug synthesis AI platform with a $4.6M seed roundTechCrunch+•Jun 01, 2021•Molecule.one, Atmos Ventures, AME Cloud Ventures, Cherubic Ventures and 3 others
•
•
